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ABSTRACT
Site-selective scission of ribonucleic acids (RNAs)
has attracted considerable interest, since RNA is an
intermediate in gene expression and the genetic
material of many pathogenic viruses. Polyamine-
imidazole conjugates for site-selective RNA scis-
sion, without free imidazole, were synthesized and
tested on yeast phenylalanine transfer RNA. These
molecules catalyze RNA hydrolysis non-randomly.
Within the polyamine chain, the location of the
imidazole residue, the numbers of nitrogen atoms
and their relative distances have notable in¯uence
on cleavage selectivity. A norspermine derivative
reduces the cleavage sites to a unique location, in
the anticodon loop of the tRNA, in the absence of
complementary sequence. Experimental results are
consistent with a cooperative participation of an
ammonium group of the polyamine moiety, in addi-
tion to it's binding to the negatively charged ribose-
phosphate backbone, as proton source, and the
imidazole moiety as a base. There is correlation
between the location of the magnesium binding
sites and the RNA cleavage sites, suggesting that
the protonated nitrogens of the polycationic chain
compete with some of the magnesium ions for RNA
binding. Therefore, the cleavage pattern is speci®c
of the RNA structure. These compounds cleave at
physiological pH, representing novel reactive
groups for antisense oligonucleotide derivatives or
to enhance ribozyme activity.
INTRODUCTION
Nucleic acids, although not endowed with the functional
diversity of protein enzymes, are suited for sequence-speci®c
recognition of RNAs through Watson±Crick base pairing.
Molecules in development include antisense oligonucleotides
and peptide nucleic acids (PNA) (1), RNA enzymes or
ribozymes (2) and RNA-cleaving DNA enzymes (3).
Combined strategies have recently emerged, using the
substrate-recognition properties of nucleic acid enzyme
together with the chemical functionality of proteins (4±6) or
with various metal ions (7). Alternative strategies for site-
selective RNA hydrolysis can be achieved by coupling small
organic molecules that have af®nity for the negatively charged
ribose-phosphate backbone of RNAs to speci®c chemical
functionalities of protein enzymes (8). At physiological pH,
high concentrations of imidazole cleave preferentially RNA
single strands (¯exibility of the ribose-phosphate backbone
required in the hydrolysis intermediate) and can be used to
probe RNA structures (9). To improve selectivity, compounds
with one or two imidazole residues conjugated to polycationic
structures (10,11), intercalating dyes (12), oligonucleotides
(13) or DNAzyme (4±6) were designed and tested on RNA
models.
In this study, we have assessed the capacities of polyamine-
imidazole conjugates for site-selective RNA scission. The
in¯uence of the polyamine length, the number of nitrogen
atoms, the location of the imidazole group, on cleavage
selectivity was assayed. One conjugate cleaves the target RNA
at a unique location within one of its functional domains
without using sequence-speci®c recognition through base
pairing. The cleavage sites were mapped onto the RNA
structure in which the position of a spermine and several
magnesium ions is de®ned with accuracy. The speci®c




Alkaline phosphatase and T4 polynucleotide kinase are from
New England Biolabs (Beverly, MA). RNases U2 and T1
are from Amersham-Pharmacia-Biotech (Orsay, France).
[g-32P]ATP (3000 mCi/mmol) is from Perkin Elmer (Boston,
MA). Escherichia coli transfer-messenger (tm)RNA-tRNA-
like domain (TLD) is over-expressed in E.coli cells and
puri®ed as described (14). Appropriate bands are electroeluted
and pure RNAs are recovered by ethanol precipitation. Total
tRNA from E.coli is from Sigma-Aldrich (Saint-Quentin,
France). Partially puri®ed yeast tRNAPhe was a gift from
D. Rhodes (MRC, Cambridge, UK). The RNA mixture
containing substantial amounts of precursor tRNAPhe was gel
puri®ed onto a 12% PAGE, electroeluted and ethanol
precipitated.
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Site-selective RNA hydrolysis
Labeling at the 5¢-ends of yeast tRNAPhe and of tmRNA-TLD
is performed with [g-32P]ATP and phage T4 polynucleotide
kinase on RNA dephosphorylated previously with alkaline
phosphatase. After labeling, the RNAs are gel puri®ed (12%
PAGE), eluted and ethanol precipitated. Labeled RNAs
(50 000 c.p.m./assay) supplemented with 1 mg of total tRNA
from E.coli are heated for 3 min at 80°C in RNase-free water,
cooled down for 5 min at room temperature, placed in a 10 mM
Tris±HCl pH 7.5 (37°C), 1 mM EDTA and 12 mM MgCl2
buffer, and incubated for 10 min at room temperature.
Reaction mixtures (20 ml) contain 200 000 c.p.m. of
[32P]tRNAPhe or [32P]tmRNA-TLD, increasing amounts of
the selected imidazole-polyamine conjugates (the pellet
containing the puri®ed compound was resuspended into a
100 mM Tris±HCl buffer pH 7.5 at 37°C). After an incubation
of 3±4 h at 37°C, RNAs are ethanol precipitated, the pellets are
washed twice with 80% EtOH, dried and counted. Then, the
RNA fragments are submitted to either 8 or 12% PAGE. For
the reaction of site-selected hydrolysis of labeled yeast
tRNAPhe with increasing concentrations of imidazole (buf-
fered at pH 7 using a 325 mM HCl solution), the reaction is
carried out as described above, but the incubation time is 12 h
at 37°C. The reaction is stopped by 20 ml 0.3 M Na acetate
(pH 5.0), 400 ml of 2% lithium per chlorate in acetone. After
centrifugation, the pellets are resuspended and washed with
300 ml acetone, dried, counted, supplemented with loading
buffer and submitted to PAGE. Samples for the Gs and As
ladders using RNAses T1 and U2, respectively, contain
labeled RNAs (50 000 c.p.m./assay), 1 mg of total tRNA in a
T1 (7 M urea, 25 mM Na citrate pH 4.5, 1 mM EDTA) or U2
(7 M urea, 30 mMNa citrate pH 3.5) buffers, incubated 10 min
at 50°C and then placed on ice. 0.4 U of RNAse T1 (Gs) or
0.2 U of RNAse U2 (As) are added followed by an incubation
of 10 min at 50°C, supplemented with loading buffer and
submitted to PAGE. All the results are analyzed on a Phosphor
Imager (Molecular Dynamics, Sunnyvale, CA). Computer
modeling was achieved with Insight II (Mountain View, CA)
on a 02 workstation.
RESULTS
Synthesis of the polyamines conjugates
Structures of polyamine conjugates used in this study are
presented in Figure 1A. Compound 1 was prepared according
to the method reported by J.P.Behr and co-workers, i.e.
biscyanoethylation of ornithine, hydrogenation, protection of
the amino groups, condensation of the N-hydroxysuccinimide
ester with histamine and ®nal deprotection with tri¯uoroacetic
acid (15). Although, as it was shown in this sequence, the free
imidazole functionality was compatible with the coupling
reaction, N-tritylhistamine (16) was preferred for the synthesis
of 2±7 to increase solubility of the intermediates and to
simplify puri®cation steps. The histamine moiety was attached
via a glycine linker directly to the amino group(s) of the
polyamine core to avoid the presence of a stereogenic center,
as in compound 1, and to make syntheses easier (Fig. 1B) (17).
Regioselective diprotected tri- and tetra-amines 8, 9 and 10
were ®rst synthesized, respectively, from spermidine, nor-
spermine and spermine and Boc2O (18) while N
1,N4,N9-triBoc
spermine was prepared according to the multi-step protocol of
Blagbrough and Geall (19). These di- or tri-protected
polyamines were converted to their glycine derivatives 12±
14 and 17 by reaction with one equivalent of benzyl
bromoacetate followed by a catalytic hydrogenation (20). In
the case of norspermine and spermine derivatives 13, 14 and
17, the cleavage of the benzyl ester was preceded by the
protection of the last free amino group as tertiobutylcarba-
mate. Dialkylated norspermine and spermine derivatives 15
and 16 were similarly obtained by using two equivalents of
alkylating agent. Imidazole conjugates 2±7 were then
synthesized by coupling the corresponding mono- or diacids
with N-tritylhistamine under standard conditions, followed by
complete deprotection with tri¯uoroacetic acid.
RNA hydrolysis assays
In the presence of an imidazole buffer, the RNA is cleaved at
seven locations (Fig. 2), in the acceptor stem (U6±U8, only at
high concentration of imidazole), in the D-loop (a strong
cleavage site is at G15, weaker ones at D17 and G19) and in
the anticodon loop (A36). Free imidazole hydrolyzes RNA at
concentrations above 100 mM. The T stem±loop, as well as
the D- and anticodon-stems, are not cleaved. Figure 3 brings
the experimental support that compound 1 is able to hydrolyze
RNA by itself at selective sites, in the absence of free
imidazole. The RNA model is native yeast tRNAPhe whose
structure has been solved recently at ~2 AÊ resolution with a
molecule of spermine and magnesium ions (21,22). There are
six main cleavage sites, two strong ones, U8 at the junction
between the acceptor and D-stems and C13 in the D-stem, and
four weaker ones, G26±C27 at the junction between the D and
anticodon-stems and U59±C60 in the T-loop. Cleavage occurs
at and above 50 mM concentration of compound 1. The
experimental controls carried out in the presence of either
spermine or spermidine at concentrations of 10, 50, 100 and
250 mM have been performed on tRNAPhe. Both spermine and
spermidine do not cleave tRNAPhe by themselves from 10 to
100 mM concentrations, but two cuts appear at positions 37
and 47 for a 250 mM concentration for both polyamines (not
shown).
The tRNA portion of tmRNA, a small RNA that interacts
with selected translating ribosomes to target the nascent
polypeptides for degradation (23), is also subjected to speci®c
hydrolysis in the presence of 1 without free imidazole (Fig. 4).
There are three main cleavage sites, two in the D-analog (C11
and C18) and one in the T-loop (C41), indicating that various
RNAs can be hydrolyzed by compound 1 without free
imidazole. The solution conformation of tmRNA-TLD was
recently monitored by structural probes, with evidence
indicating that both C11 and C41 are accessible towards
structural probes speci®c of single-stranded RNA sequences
(14). Therefore, 2 nt out of the 3 that are cleaved by
compound 1 are accessible. Their cleavage by 1 is probably a
consequence of the intrinsic structure of tmRNA-TLD.
Varying the position of the imidazole with respect to the
polycationic chain was achieved with compounds 1, 2 and 3
(Fig. 5). The imidazole-containing lateral chain is branched on
an internal carbon (1), nitrogen (2) or terminal nitrogen (3),
respectively. 2 cleaves tRNAPhe at three positions similar to
those observed with 1 (U8, C13 more weakly and C27). Two
additional sites are in the anticodon loop, at A36 and A38. 3
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Figure 1. Chemical structures (A) and scheme of synthesis (B) of seven polyamine derivatives for RNA hydrolysis.
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does not cleave the RNA, even at a 250 mM concentration
(Fig. 5).
Next, the structure of the polycationic chain was modi®ed,
without affecting the imidazole-containing lateral branch
(compounds 4 and 5; Fig. 1). For conjugate 4, a spermidine
derivative, cleavage sites become restricted to U8 and A38
(Fig. 5). Compared with 1, the lateral branch of compound 4
connects an internal amine and not an internal carbon,
modifying the positioning of the lateral branch with respect
to the polycationic chain. Interestingly, in the case of 5, only
one cleavage site remains, at position 38 in the anticodon loop
(Fig. 5). Di-imidazole derivatives (compounds 6 and 7) trigger
RNA cleavage at a much lower concentration compared with
their mono-imidazole counterparts, since cleavage is observed
at 5 mM. For 6, cleavage occurs at U8 and A38, and U8, C13,
C27 and A38 for 7, but with a loss of selectivity around 10 mM
for 7.
DISCUSSION
Site-speci®c RNA cleavage by imidazole-containing poly-
amine compounds is described in the absence of free
Figure 3. Yeast tRNAPhe hydrolysis by compound 1. (A) Electrophoregram of the cleavage pattern. The indications provided are as in Figure 2A.
(B) Cleavage points (circles, with a thickness that is proportional to the intensity of the cuts) mapped onto yeast tRNAPhe secondary structure.
Figure 2. Electrophoregram of the cleavage pattern of labeled tRNAPhe by an imidazole buffer. (A) Lane C, incubation control; lane OHL, alkaline hydrolysis
ladder; lane GL, guanine ladder; lane AL, adenine ladder. Sequence is indexed on the left side. Nucleotides indexed on the right side are the cleavage sites.
(B) Yeast tRNAPhe secondary structure with imidazole induced cleavage points. Thickness of the symbols (rectangles) is proportional to the intensity of the
cuts. Nucleotides at the 5¢-boundary of the cleavage sites are indicated onto tRNAPhe secondary structure, the cleavage sites are at the 3¢-phosphate. This
molecule has 11 modi®ed bases: N2-methylguanosine (m2G), dihydrouridine (D), N2,N2-dimethylguanosine (m22G), 2¢-O-methylcytidine (Cm),
2¢-O-methylguanosine (Gm), wybutosine (yW), pseudouridine (Y), 5-methylcytidine (m5C), 7-methylguanosine (m7G), 5-methyluridine (m5U) and
1-methyladenosine (m1A).
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imidazole. Varying the position of the imidazole and the
structure of the polycationic chain could lead to a novel
compound that triggers a unique and speci®c cleavage of the
target RNA. When two imidazoles are present, cleavages
occur at a concentration one order of magnitude lower than
when there is only one imidazole. Adding an imidazole
buffer to the mono-imidazole derivatives might reduce their
respective concentrations required for cleavage.
The imidazole rings of catalytic residues His12 and His119
in the catalytic site of RNase A serve, respectively, as base and
acid catalysts and the protonated side chain of Lys41 stabilizes
the pentacoordinated phosphorous intermediate during transi-
tion state (24). Our experimental results are consistent with a
cooperative participation of one of the amino group of the
polyamine chain, predominantly protonated at physiological
pH, as proton source, and the imidazole moiety, which is
partially unprotonated, as base. The polycationic moiety is
also involved in binding the negatively charged ribose-
phosphate backbone. Indeed, when the imidazole ring of
conjugate 1 is superimposed onto His12 from the active site of
RNase A crystal structure in complex with cytidine 3¢-
monophosphate (25), the polycationic backbone has suf®cient
length and ¯exibility to superimpose one of its protonated
amino groups on a nitrogen atom of the imidazole ring of
His119 (Fig. 6A). The same observations have been noticed
with compounds 2 and 5±7. For 3, although the bond
requirement is ful®lled, binding of the polycationic chain
onto the RNA may place the imidazole ring too far away from
the ribose-phosphate backbone. Alternatively, the longer
distance between the imidazole and the protonable nitrogens
might prevent RNA catalysis. The distance between one of the
two protonated nitrogens of the spermidine chain and the
imidazole ring of 4 is minimal, but still suf®cient to trigger
RNA hydrolysis. The number of cleavages is probably
reduced because a shorter polyamine with fewer protonated
nitrogens binds the RNA at fewer locations, including sites 1
and 3, but not 2 and 4 (Fig. 6B). When norspermine replaces
spermidine (compound 5), only A38 from site 3 is cleaved,
indicating that both the position of the polyamine moiety and
the distance between a protonated nitrogen and an imidazole
have been optimized to induce a single cleavage site.
Nevertheless, intra-molecular catalysis is not proven, and
inter-molecular catalysis cannot be excluded, especially at
such concentrations. 15N NMR spectroscopy was used to map
the interactions between natural polyamines and total tRNA
from E.coli and have shown that the internal -NH2
+- groups
bind more strongly to tRNA than the external -NH3
+ moieties
Figure 5. Site-selected hydrolysis of yeast tRNAPhe by compounds 1±7. The indications provided are as in Figure 2A.
Figure 4. Hydrolysis of the tRNA portion of tmRNA by compound 1. (A)
Electrophoregram of the cleavage pattern. The indications provided are as
in Figure 2A. The star shows an example of a cleavage site that was
not retained since it is already present in the control lane.
(B) Cleavage points mapped onto the RNA secondary structure (27).
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(26). Thus, substitutions of the secondary amines in
conjugates 4, 6 and 7 might affect their binding to tRNAPhe.
Yeast tRNAPhe structure has density for a spermine in the
major groove of the TYC stem, as well as accurate inform-
ation on the location of Mg2+ binding sites. The location of the
cleavage sites triggered by conjugates 1±7 is indicated [Fig. 6;
the 2¢-OH from the attacked riboses (r) and the hydrolyzed
phosphates (p) are displayed]. The cleavage sites are clustered
into four areas (sites 1±4). In site 1, two cleavage sites are
opposite since the sugar-phosphate backbone loops back
between U8 and C13; in that cleft, there are Mg2+ binding sites
that could be occupied by some of the protonated nitrogens of
the polycationic chain. Nearby sites 2 and 3, Mg2+ binding
sites could be favored anchoring points for the protonated
nitrogens of the conjugates. Site 4 is close to the binding site of
spermine, suggesting that the triamine moiety might bind at a
similar location; alternatively, there are Mg2+ binding sites
within the T- and D-loops that could be displaced by
protonated nitrogens of the polycationic chain. Three addi-
tional Mg2+ binding sites are in the acceptor stem that prevents
hydrolysis intermediate state formation.
In conclusion, novel RNaseA mimics that do not depend
upon free imidazole for RNA cleavage were designed,
synthesized and tested on an RNA whose detailed atomic
structure is known. One conjugate cleaves the RNA target
at a unique location within one of its main functional
domains, without using sequence-speci®c recognition
through base pairing. There is correlation between the
location of the magnesium binding sites from the RNA target
and the cleavages sites. Further investigations of other
imidazole derivatives are currently in progress in our labora-
tories.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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